Letter to the editor: Liver transarterial chemoembolization plus sunitinib for unresectable hepatocellular carcinoma

被引：0
|
作者：
Fang, Zhiyuan [1 ]
Yang, Huayu [1 ]
Mao, Yilei [1 ]
机构：
[1] PUMC & Chinese Acad Med Sci, Peking Union Med Coll PUMC Hosp, Dept Liver Surg, 1 Shuaifuyuan, Beijing, Peoples R China
来源：
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY | 2022年 / 46卷 / 09期
关键词：
D O I：
10.1016/j.clinre.2022.101984
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Liver transarterial chemoembolization and sunitinib for unresectable hepatocellular carcinoma: Results of the PRODIGE 16 study
    Turpin, Anthony
    de Baere, Thierry
    Heurgue, Alexandra
    Le Malicot, Karine
    Ollivier-Hourmand, Isabelle
    Lecomte, Thierry
    Perrier, Herve
    Vergniol, Julien
    Sefrioui, David
    Rinaldi, Yves
    Edeline, Julien
    Jouve, Jean-Louis
    Silvain, Christine
    Becouarn, Yves
    Dauvois, Barbara
    Baconnier, Mathieu
    Debette-Gratien, Maryline
    Deplanque, Gael
    Dharancy, Sebastien
    Lepage, Come
    Hebbar, Mohamed
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2021, 45 (02)
  • [2] Sorafenib plus transarterial chemoembolization for unresectable hepatocellular carcinoma
    Tsilimigras, Diamantis I.
    Pawlik, Timothy M.
    ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (23)
  • [3] Sunitinib versus sorafenib plus transarterial chemoembolization for inoperable hepatocellular carcinoma patients
    Xu, Qiang
    Huang, Youhua
    Shi, Hongjian
    Song, Qian
    Xu, Yuanfeng
    JOURNAL OF BUON, 2018, 23 (01): : 193 - 199
  • [4] Effectiveness of transarterial chemoembolization combined with lenvatinib plus sintilimab in unresectable hepatocellular carcinoma
    Cao, Fei
    Yang, Yi
    Si, Tongguo
    Luo, Jun
    Zeng, Hui
    Zhang, Zhewei
    Chen, Yi
    Zheng, Jiaping
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [5] A randomized controlled trial of thymalfasin plus transarterial chemoembolization for unresectable hepatocellular carcinoma
    Gish, Robert G.
    Gordon, Stuart C.
    Nelson, David
    Rustgi, Vinod
    Rios, Israel
    HEPATOLOGY INTERNATIONAL, 2009, 3 (03) : 480 - 489
  • [6] Safety of transarterial chemoembolization plus sorafenib combination treatment in unresectable hepatocellular carcinoma
    Sinakos, Emmanouil
    Dedes, Ioannis
    Papalavrentios, Lavrentis
    Drevelegas, Antonios
    Akriviadis, Evangelos
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2010, 45 (04) : 511 - 512
  • [7] A randomized controlled trial of thymalfasin plus transarterial chemoembolization for unresectable hepatocellular carcinoma
    Robert G. Gish
    Stuart C. Gordon
    David Nelson
    Vinod Rustgi
    Israel Rios
    Hepatology International, 2009, 3 : 480 - 489
  • [8] Transarterial chemoembolization in children to treat unresectable hepatocellular carcinoma
    Weiss, Krista E.
    Sze, Daniel Y.
    Rangaswami, Arun A.
    Esquivel, Carlos O.
    Concepcion, Waldo
    Lebowitz, Edward A.
    Kothary, Nishita
    Lungren, Matthew P.
    PEDIATRIC TRANSPLANTATION, 2018, 22 (04)
  • [9] Sequential transarterial chemoembolization for unresectable advanced hepatocellular carcinoma
    Jaeger, HJ
    Mehring, UM
    Castaneda, F
    Hasse, F
    Blumhardt, G
    Loehlein, D
    Mathias, KD
    CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 1996, 19 (06) : 388 - 396
  • [10] Chemotherapy for transarterial chemoembolization in patients with unresectable hepatocellular carcinoma
    Jie Wu
    Lei Song
    Dan-Yi Zhao
    Bing Guo
    Jing Liu
    World Journal of Gastroenterology, 2014, (31) : 10960 - 10968
12345